BRX News
Brixmor Property Group Inc.
$30.32
+$0.06(+0.20%)
72
Overall
100
Value
66
Tech
50
Quality
Market Cap
$9.30B
Volume
778.13K
52W Range
$24.66 - $32.86
Target Price
$33.66
BRX news: the latest Brixmor Property Group Inc. headlines, press releases and market updates, newest first.
Latest BRX News
- Moleculin Biotech Announces Australian Patent for Annamycin FormulationTipRanks Auto-Generated Newsdesk · Nov 12, 2026
- UBS Sticks to Their Buy Rating for Brixmor Property (BRX)TipRanks Auto-Generated Intelligence Newsdesk · Nov 11, 2026
- Moleculin Reports Annamycin Combination Data in Pancreatic CancerTipRanks Auto-Generated Newsdesk · Nov 10, 2026
- ImmunityBio Reports Positive ANKTIVA Bladder Cancer Trial ResultsTipRanks Auto-Generated Newsdesk · Nov 9, 2026
- H.C. Wainwright Reaffirms Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)TipRanks Auto-Generated Intelligence Newsdesk · Nov 9, 2026
- Analysts Offer Insights on NA Companies: SpaceX (SPCX), Six Flags Entertainment Corporation (FUN) and LB Pharmaceuticals, Inc. (LBRX)TipRanks Newsroom · Oct 21, 2026
- Upcoming Stock Splits This Week (October 19 to October 23) – Stay InvestedBen Yoffe · Oct 18, 2026
- Moleculin Biotech Updates Investors With New PresentationTipRanks Auto-Generated Newsdesk · Oct 16, 2026
- Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), ImmunityBio (IBRX) and vTv Therapeutics (VTVT)TipRanks Newsroom · Oct 15, 2026
- ImmunityBio gains FDA expansion for ANKTIVA bladder therapyTipRanks Auto-Generated Newsdesk · Oct 14, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BRX | $30.32 | +0.2% | 778.13K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Brixmor Property Group Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW